A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects with Primary Indeterminate Lesions or Small Choroidal Melanoma
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Aura Biosciences, Inc.
Start Date
July 30, 2024
End Date
July 31, 2029
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Aura Biosciences, Inc.
Start Date
July 30, 2024
End Date
July 31, 2029